The transaction involves approximately 1,500 Azimut investors and is carried out through a Luxembourg-based vehicle
The start-up closes its first round and focuses on the solution that enables companies to develop fiscal efficiency
The French start-up develops vaccines against cancer and, with this funding, aims to move on to the next clinical phase
The German start-up receives capital in a Series B round led by Gimv and EQT Life Sciences and prepares for the second phase of clinical trials
The start-up focuses on solutions to prevent and treat obesity through the use of digital tools
The start-up has developed a technology to protect the authenticity of products, including in the second-hand market
The start-up aims to expand throughout the country and has also launched an academy project to train instructors
Click here to read previous Newsletters
Subscribe to the newsletter
yes
en
* I agree that my personal data will be used in accordance with the Privacy and Cookie Policy.
* I authorize the processing of my personal data to be updated on new arrivals and for direct marketing purposes related to the services offered.
